These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17137555)

  • 1. Proteomics-based identification of biomarkers for predicting sensitivity to a PI3-kinase inhibitor in cancer.
    Akashi T; Nishimura Y; Wakatabe R; Shiwa M; Yamori T
    Biochem Biophys Res Commun; 2007 Jan; 352(2):514-21. PubMed ID: 17137555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SELDI protein profiling of dunning R-3327 derived cell lines: identification of molecular markers of prostate cancer progression.
    Malik G; Rojahn E; Ward MD; Gretzer MB; Partin AW; Semmes OJ; Veltri RW
    Prostate; 2007 Oct; 67(14):1565-75. PubMed ID: 17705230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SELDI-TOF-MS proteomics of breast cancer.
    Clarke CH; Buckley JA; Fung ET
    Clin Chem Lab Med; 2005; 43(12):1314-20. PubMed ID: 16309366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening of differentially expressed proteins associated with directional highly lymphatic metastasis in ovarian carcinoma cell lines using SELDI-TOF-MS technology].
    Guan X; Li DR; Wang Q; Li L; Ruan HY; Zhang W
    Ai Zheng; 2008 Nov; 27(11):1155-60. PubMed ID: 19000445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
    Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
    Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
    Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
    Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
    Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway.
    Nguyen DM; Chen GA; Reddy R; Tsai W; Schrump WD; Cole G; Schrump DS
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):365-75. PubMed ID: 14762343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
    Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkers.
    Rai AJ; Stemmer PM; Zhang Z; Adam BL; Morgan WT; Caffrey RE; Podust VN; Patel M; Lim LY; Shipulina NV; Chan DW; Semmes OJ; Leung HC
    Proteomics; 2005 Aug; 5(13):3467-74. PubMed ID: 16052624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteome analysis for the identification of tumor-associated biomarkers in gastrointestinal cancer.
    Fels LM; Buschmann T; Meuer J; Reymond MA; Lamer S; Röcken C; Ebert MP
    Dig Dis; 2003; 21(4):292-8. PubMed ID: 14752218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
    Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y
    Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LY294002, an inhibitor of PI-3K, enhances heat sensitivity independently of p53 status in human lung cancer cells.
    Ohnishi K; Yasumoto J; Takahashi A; Ohnishi T
    Int J Oncol; 2006 Jul; 29(1):249-53. PubMed ID: 16773206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
    Solassol J; Marin P; Maudelonde T; Mangé A
    Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen biomarkers for early diagnosis of lung adenocarcinoma].
    Tian YX; Yang SY; Nan YD; Zhang W; Yu JK; Zheng S
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):157-61. PubMed ID: 19292069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
    Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
    Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
    Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
    Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.